Overview
Youlan Shang practices practicing medicine in Changsha, China.
Their clinical expertise encompasses Lung Adenocarcinoma, Insulinoma, Lung Cancer, and EGFR Positive Lung Cancer.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Youlan Shang
Is Youlan Shang a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Youlan Shang is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Youlan Shang participate in research or clinical trials?
Yes. Youlan Shang has published 8 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Youlan Shang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerShang isExperienced. Learn about EGFR Positive Lung Cancer.
- InsulinomaShang isExperienced. Learn about Insulinoma.
- Lung AdenocarcinomaShang isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerShang isExperienced. Learn about Lung Cancer.